Related references
Note: Only part of the references are listed.Quality assurance of integrative big data for medical research within a multihospital system
Yi-Chia Lee et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress
Milton Packer
CARDIOVASCULAR RESEARCH (2021)
Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus
Jung-Chi Hsu et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Diabetes mellitus is associated with an increased incidence of aortic valve stenosis
Christoph Roderburg et al.
DIABETES & VASCULAR DISEASE RESEARCH (2021)
Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
Magdalena Kopytek et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
Thomas A. Zelniker et al.
CIRCULATION (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies
Helena C. Kenny et al.
CIRCULATION RESEARCH (2019)
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker et al.
LANCET (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies
Inder S. Anand et al.
CIRCULATION (2018)
Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis
Ariane Testuz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Association Between Cardiovascular Risk Factors and Aortic Stenosis The CANHEART Aortic Stenosis Study
Andrew T. Yan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Medical Treatment of Aortic Stenosis
Guillaume Marquis-Gravel et al.
CIRCULATION (2016)
Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis
Ting-Tse Lin et al.
KIDNEY INTERNATIONAL (2015)
Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes
Zhongqun Wang et al.
ATHEROSCLEROSIS (2012)
Does Diabetes Accelerate the Progression of Aortic Stenosis through Enhanced Inflammatory Response within Aortic valves?
Joanna Natorska et al.
INFLAMMATION (2012)
Burden of valvular heart diseases: a population-based study
Vuyisile T. Nkomo et al.
LANCET (2006)
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Gillian L. Booth et al.
LANCET (2006)
Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis
R Katz et al.
CIRCULATION (2006)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
Share Paper
